Abhishek Paserkar։ Revolutionizing Hypertriglyceridemia Treatment With Olezarsen
Abhishek Paserkar, Medical Doctor, shared a post on LinkedIn:
՛՛Revolutionizing Hypertriglyceridemia Treatment!
Excited to dive into this groundbreaking review on Olezarsen (Tryngolza) – the next-gen GalNAc-conjugated antisense oligonucleotide targeting ApoC-III for severe hypertriglyceridemia and Familial Chylomicronemia Syndrome (FCS)!
Published in Cureus (Nov 2025) by Joshy et al., it highlights how olezarsen slashes triglycerides by ~60% in FCS patients over 12 months, dramatically cutting pancreatitis events (just 1 vs. 11 on placebo in BALANCE trial)!
Key Highlights
Mechanism Magic: Inhibits hepatic ApoC-III, boosting LPL-dependent and independent triglyceride clearance – even in LPL-deficient FCS!
Trial Triumphs: Phase 3 BALANCE: TG decreased 59%, ESSENCE: decreased 58-61% in moderate HTG + CV risk. Ongoing CORE trials target pancreatitis prevention in severe HTG.
Safety Superstar: Mild injection-site reactions only; no thrombocytopenia like older volanesorsen. Monthly 80mg SC dose – convenient and tolerable!
This precision therapy (FDA-approved Dec 2024) transforms management of life-threatening TG disorders, paving the way for CV risk reduction. A must-read for pharmacologists, endocrinologists and lipid experts! ՛՛

Stay updated with Hemostasis Today.
-
Feb 3, 2026, 15:52Maximo Agustin Schiavone: What Does ‘Risk-Factor-Free MI’ Really Mean in Practice?
-
Feb 3, 2026, 15:44Daniel Torrent: A New Path for ‘No-Optional’ Patients – TADV vs Standard of Care in CLTI
-
Feb 3, 2026, 15:11Latest News from the WHO Executive Board Session in Geneva – WFH
-
Feb 3, 2026, 14:54300 Million People, One Global Community – Rare Disease Day
-
Feb 3, 2026, 14:33Pedro Henrique Las Casas: VTE After BCMA Directed CAR T-Cell Therapy in Multiple Myeloma
-
Feb 3, 2026, 14:26Anuoluwapo Babalola։ What The U.S. Exit from WHO Means for Global Health Leadership
-
Feb 3, 2026, 14:16Michiel Voet: Why Every Military Should Have a Dedicated Blood Unit
-
Feb 3, 2026, 10:53Aurelio Maggio: The Final Chapter of Our Journey Through Thalassemia
-
Feb 3, 2026, 10:40Pedro Perez: Post-Thrombectomy DVT Recovery in 2026 – Closing the Loop on Outcomes